# Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer

> **NCT07488312** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Qilu Hospital of Shandong University** · enrollment: 37 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Leucine-restricted diet.

## Key facts

- **NCT ID:** NCT07488312
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-10-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07488312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07488312, "Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07488312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*